 |
P1, P4-Di(uridine 5′-tetraphosphate), tetrasodium salt |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1998-10-27 00:00:00 |
| Sponsor | Inspire Pharmaceuticals, Inc.;4222 Emperor Blvd., Suite 470;Durham, North Carolina, 27703 |
Related Access Program